Preclinical Efficacy of Daratumumab in T Cell Acute Lymphoblastic Leukemia |
New York University School of Medicine / Karen Bride, MD/PhD |
Young Investigator Grants |
2017 |
New York |
End-of-Life Care of Children with Cancer: Variation and Stakeholder Priorities |
University of Alabama at Birmingham / Emily Johnston, MD |
Young Investigator Grants |
2017 |
Alabama |
Identification and Targeting of Microenvironmental Factors Controlling Pediatric Leukemia |
New York University School of Medicine / Anastasia Tikhonova, PhD |
Young Investigator Grants |
2017 |
New York |
Identification and Characterization of Pathways Dysregulated by MMSET E1099K Mutation in Relapsed Pediatric Acute Lymphoblastic Leukemia and Their Role in Drug Resistance |
New York University School of Medicine / Joanna Pierro, DO |
Young Investigator Grants |
2017 |
New York |
Elucidating the Role of N-Myc in a High-risk Pediatric T Cell Leukemia |
New York University School of Medicine / Francesco Boccalatte, PhD |
Young Investigator Grants |
2017 |
New York |
Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors |
Jewish General Hospital / Bárbara Rivera, PhD |
Young Investigator Grants |
2017 |
Quebec |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Development of Novel Biomarkers for Immunotherapy in Neuroblastoma |
Columbia Institute for Cancer Genetics / Shuobo Boboila, PhD |
Young Investigator Grants |
2017 |
New York |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |